CMS releases proposed rule for CY2027 Medicare Advantage and Part D programs with key changes to Part D redesign, Star Ratings, special enrollments, and marketing compliance. Regulatory updates impact plan operations, quality metrics, and data access.

The GAO report reveals significant enforcement gaps in detecting and preventing fraud among ACA Marketplace agents and brokers, highlighting the need for strengthened regulatory oversight to protect taxpayer funds and ensure market stability.

By 2025, expiration of enhanced ACA subsidies and Medicaid funding cuts are poised to reshape U.S. health coverage, with new eligibility rules and rural grants influencing state programs and providers.

KFF analysis of 2022 Medicare Advantage data shows 17% had diagnosis additions increasing CMS payments, with minimal diagnosis deletions impacting risk adjustments.

Negotiations to extend enhanced ACA health insurance premium subsidies before the deadline face significant Republican divisions over abortion funding and policy reforms, complicating bipartisan progress.

The future of Affordable Care Act marketplace subsidies is uncertain as political gridlock delays extension votes amid 2026 open enrollment.

CMS's WISeR Model introduces AI-powered prior authorization for Medicare outpatient procedures, impacting approval times and denials in six states starting 2026.

Congress confronts a critical deadline to extend Affordable Care Act subsidies amid partisan divisions, impacting health insurance markets and regulatory compliance.

CMS releases Proposed 2027 Rules for Medicare Advantage and Part D, emphasizing Star Ratings simplification, marketing oversight updates, expanded risk adjustment data use, and Part D redesign implementation.

Hospitals challenge HHS's 340B pilot shifting drug discounts to a rebate system, citing financial risks and regulatory concerns.